endobulin kiovig
baxalta brasil biociÊncia ltda - imunoglobulinas
endobulin s/d
baxter hospitalar ltda - imunoglobulinas
nuovodox
laboratÓrio quÍmico farmacÊutico bergamo ltda - antineoplasicos citotoxicos
skyrizi
abbvie deutschland gmbh & co. kg - risankizumab - psoriasis; arthritis, psoriatic - imunossupressores - plaque psoriasisskyrizi is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisskyrizi, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). crohn's diseaseskyrizi is indicated for the treatment of adult patients with moderately to severely active crohn's disease who have had an inadequate response to, lost response to, or were intolerant to conventional therapy or a biologic therapy.
comirnaty
pfizer brasil ltda - vacina covid-19 - vacinas
kitapen
biolab sanus farmacÊutica ltda - hemifumarato de quetiapina - antipsicoticos
hygroton 50 mg comprimido
amdipharm ltd - clorotalidona - comprimido - 50 mg - clorotalidona 50 mg - chlortalidone - n/a - duração do tratamento: longa duração
hygroton 50 mg comprimido
amdipharm ltd - clorotalidona - comprimido - 50 mg - clorotalidona 50 mg - chlortalidone - n/a - duração do tratamento: longa duração
hygroton 50 mg comprimido
amdipharm ltd - clorotalidona - comprimido - 50 mg - clorotalidona 50 mg - chlortalidone - n/a - duração do tratamento: longa duração
belkyra
allergan produtos farmacÊuticos ltda - Ácido desoxicÓlico -